The Dow Jones Industrial and S&P 500 hovered near their record highs on Monday as investors react to an overall upbeat earnings reports from companies and pare safe-haven assets as situation in Turkey after a failed coup attempt seems to stabilize. Among the most noteworthy stocks on the investors’ radar today include ZAIS Financial Corp (NYSE:ZFC), Burlington Stores Inc (NYSE:BURL), ParkerVision, Inc. (NASDAQ:PRKR), Brainstorm Cell Therapeutics Inc(NASDAQ:BCLI), and Digital Ally, Inc. (NASDAQ:DGLY). Let’s find out why these stocks are attracting attention today and analyze hedge funds sentiment towards them.
At Insider Monkey, we track around 765 hedge funds and institutional investors. Through extensive backtests, we have determined that imitating some of the stocks that these investors are collectively bullish on, can help retail investors generate double digits of alpha per year. The key is to focus on the small-cap picks of these funds, which are usually less followed by the broader market and allow for larger price inefficiencies (see the details here).
Investigation Initiated Against ZAIS Financial
ZAIS Financial Corp (NYSE:ZFC) is trading in the red today after law firm Andrews & Springer announced that it was investigating a potential securities violations and breach of fiduciary duty claims against ZAIS Financial Corp. The firm invited shareholders of the company to contact it in order to get additional information and “protect” their investment. Only five hedge funds out of those tracked by us were long ZAIS Financial Corp (NYSE:ZFC) at the end of the first quarter. Jim Simons’ Renaissance Technologies is one of these hedge funds.
Follow Ready Capital Corp (NYSE:RC)
Follow Ready Capital Corp (NYSE:RC)
Burlington Increases Its Q2 Guidance
Burlington Stores Inc (NYSE:BURL) stock has increased by 5% to its new 52-week high after the company upped its second quarter guidance. The apparel company now expects its second quarter comparable sales to increase by 4.2%-4.5%, up from the previous estimate of 2.5% -3.5% increase. Burlington Stores sees its net income at $0.28-$0.30, sharply up from the previous guidance of $0.20-$0.23. The company also said that it will reveal its full year guidance in its second quarter results, which are expected to be announced on September 6, according to FactSet. A total of 37 hedge funds from our database of about 766 funds were bullish on Burlington Stores Inc (NYSE:BURL) at the end of the first quarter.
Follow Burlington Stores Inc. (NYSE:BURL)
Follow Burlington Stores Inc. (NYSE:BURL)
Move on to the next page to see why ParkerVision, Brainstorm Cell Therapeutics and Digital Ally are making headlines today.
ParkerVision Settles Its Disputes with Samsung
ParkerVision, Inc. (NASDAQ:PRKR)’s stock has spiked 62.61% so far today after the company said it had entered into a settlement and patent license agreement with Samsung Electronics Co., Ltd. and its affiliates for the license of ParkerVision’s current patent portfolio. According to the terms of the agreement, ParkerVision will file a motion to remove Samsung from a pending U.S. International Trade Commission investigation and dismiss its claims against the Korean tech giant in two cases in the US District Court. In a statement, ParkerVision’s CEO Jeffrey Parker said that the company is pleased to welcome Samsung as a licensee of its technologies and dismiss the outstanding litigations. Marc Lisker, Glenn Fuhrman and John Phelan’s MSDC Management is one of 4 hedge funds from our database having shares of ParkerVision at the end of March.
Follow Parkervision Inc (NASDAQ:PRKR)
Follow Parkervision Inc (NASDAQ:PRKR)
Brainstorm Cell Therapeutics Posts Positive Results for ASL Drug
Shares of Brainstorm Cell Therapeutics Inc(NASDAQ:BCLI) are showing massive volatility today, skyrocketing in premarket trading after the company said its phase 2 study of NurOwn in patients with Amyothrophic Lateral Sclerosis met its objectives. However, the stock is currently trading more than 5% in the red. Brainstorm Cell Therapeutics said that the study showed NurOwn is safe and “well tolerated” for the patients. In a statement, trial investigator Dr. Robert H. Brown said that the “exciting findings” from the study show that it is appropriate to start a longer study with repetitive dosing. At the end of March, three hedge funds in our system held shares of Brainstorm Cell Therapeutics Inc (NASDAQ:BCLI).
Follow Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)
Follow Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)
Digital Ally Stock Gaining
Digital Ally, Inc. (NASDAQ:DGLY) has shot up by more than 20% so far today as the shares of digital equipment makers for law enforcement continue to gain following shooting rampages in Dallas and Baton Rouge. Several reports suggested that the police used body cameras made by companies like Taser International to capture videos of crime scenes in the recent events. David E. Shaw’s D. E. Shaw has 10,677 shares of the company, as of the end of the first quarter.
Follow Digital Ally Inc. (NASDAQ:DGLY)
Follow Digital Ally Inc. (NASDAQ:DGLY)
Disclosure: None